Crossmark

Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO)

Crossref DOI link: https://doi.org/10.1186/s13287-018-0969-z

Published Online: 2018-09-14

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bassetti, Beatrice

Carbucicchio, Corrado

Catto, Valentina

Gambini, Elisa

Rurali, Erica

Bestetti, Alberto

Gaipa, Giuseppe

Belotti, Daniela

Celeste, Fabrizio

Parma, Matteo

Righetti, Stefano

Biava, Lorenza

Arosio, Maurizio

Bonomi, Alice

Agostoni, Piergiuseppe

Scacciatella, Paolo

Achilli, Felice

Pompilio, Giulio http://orcid.org/0000-0003-2581-5735
Funding

Funding for this research was provided by:

Ministero della Salute (RF-2010-2321151)

Amici del Cuore Piemonte ONLUS (-)
License Information

Text and Data Mining valid from 2018-09-14
More Information

Article History

Received: 13 July 2018

Revised: 30 July 2018

Accepted: 2 August 2018

First Online: 14 September 2018

Ethics approval and consent to participate

: The study complied with the Declaration of Helsinki and was approved by the local ethical committees (CCFM225/612 and CS/154) and the Italian Competent Authority (Istituto Superiore di Sanità, 15,934(13)PRE21-1199). The institutional review board at each center approved the protocol and all patients gave informed consent prior to participation. Patients were excluded in the case of denial and might withdraw from the study at any time, irrespective of the reason.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below